Indeed, XMD 17-109 significantly reduced IL-6 secretion from the three lung cancer cell lines NCI-H226, NCI-H2122, and NCI-H1650 as well as from the two CAFs lines (Fig. 5d). Here, IL6 is linked to lung carcinoma.